Toxoplasma gondii inhibits Fas/CD95-triggered cell death by inducing aberrant processing and degradation of caspase 8

Cellular Microbiology

Volumn 9, Issue 6, 2007, Pages 1556-1570

  Vutova, Polya ^a   Wirth, Martina ^a   Hippe, Diana ^a   Gross, Uwe ^a   Schulze Osthoff, Klaus ^b   Schmitz, Ingo ^b   Lüder, Carsten G K ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; FAS ANTIGEN; PROCASPASE 8; PROTOZOAL PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME DEGRADATION; HOST CELL; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; CASPASE 8; CELL LINE, TUMOR; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; HUMANS; TOXOPLASMA;

TOXOPLASMA GONDII;

EID: 34248668745     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2007.00893.x     Document Type: Article

References (53)

1. Barnhart, B.C., Alappat, E.C., and Peter, M.E. (2003) The CD95 type I/ type II model. Semin Immunol 15: 185-193.
2. Beckers, C.J., Dubremetz, J.F., Mercereau-Puijalon, O., and Joiner, K.A. (1994) The Toxoplasma gondii rhoptry protein ROP2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm. J Cell Biol 127: 947-961.
3. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996) Involvement of MACH, a novel MORT1/FAAD-interacting protease, in Fas/ APO-1- and TNF receptor-induced cell death. Cell 85: 803-815.
4. Brossier, F., Jewett, T.J., Sibley, L.D., and Urban, S. (2005) A spatially localized rhomboid protease cleaves cell surface adhesions essential for invasion of Toxoplasma. Proc Natl Acad Sci USA 102: 4146-4151.
5. Carmen, J.C., Hardi, L., and Sinai, A.P. (2006) Toxoplasma gondii inhibits ultraviolet light-induced apoptosis through multiple interactions with the mitochondrion-dependent programmed cell death pathway. Cell Microbiol 8: 301-315.
6. Chun, H.J., Zheng, L., Ahmad, M., Wang, J., Speirs, C.K., Siegel, R.M., et al. (2002) Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419: 395-399.
7. Cummings, J., Ward, T.H., Ranson, M., and Dive, C. (2004) Apoptosis pathway-targeted drugs -from the bench to the clinic. Biochim Biophys Acta 1705: 53-66.
8. Denkers, E.Y., and Gazzinelli, R.T. (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11: 569-588.
9. Denkers, E.Y., Yap, G., Scharton-Kersten, T., Charest, H., Butcher, B.A., Caspar, P., et al. (1997) Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol 159: 1903-1908.
10. Dockrell, D.H. (2003) The multiple roles of Fas ligand in the pathogenesis of infectious diseases. Clin Microbiol Infect 9: 766-779.
11. Earnshaw, W.C., Martins, L.M., and Kaufmann, S.H. (1999) Mammalian caspases: Structures, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383-424.
12. Ferrari, D., Stepczynska, A., Los, M., Wesselborg, S., and Schulze-Osthoff, K. (1998) Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis. J Exp Med 188: 979-984.
13. Fischer, S.F., Harlander, T., Vier, J., and Häcker, G. (2004) Protection against CD95-induced apoptosis by chlamydial infection at a mitochondrial step. Infect Immun 72: 1107-1115.
14. Fischer, U., Janicke, R.U., and Schulze-Osthoff, K. (2003) Many cuts to ruin: A comprehensive update of caspase substrates. Cell Death Differ 10: 76-100.
15. Goebel, S., Lüder, C.G.K., and Gross, U. (1999) Invasion by Toxoplasma gondii protects human-derived HL-60 cells from actinomycin d -induced apoptosis. Med Microbiol Immunol 187: 221-226.
16. Goebel, S., Gross, U., and Lüder, C.G.K. (2001) Inhibition of host cell apoptosis by Toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alterations of poly(ADP-ribose) polymerase expression. J Cell Sci 114: 3495-3505.
17. Gubbels, M.-J., Striepen, B., Shastri, N., Turkoz, M., and Robey, E.A. (2005) Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect Immun 73: 703-711.
18. Israelski, D.M., and Remington, J.S. (1993) Toxoplasmosis in the non-AIDS immunocompromized host. Curr Clin Top Infect Dis 13: 322-356.
19. Juo, P., Kuo, C.J., Yuan, J., and Blenis, J. (1998) Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 8: 1001-1008.
20. Keller, P., Schaumburg, F., Fischer, S.F., Häcker, G., Groß, U., and Lüder, C.G.K. (2006) Direct inhibition of cytochrome c-induced caspase activation in vitro by Toxoplasma gondii reveals novel mechanisms of interference with host cell apoptosis. FEMS Microbiol Lett 258: 312-319.
21. Kim, H., Warthenby, K.A., Georgantas, R., III, Wingard, J., and Civin, C. (2002) Human CD34+ hematopoietic stem/progenitor cells express high levels of Flip and are resistant to Fas-mediated apoptosis. Stem Cells 20: 174-182.
22. Krammer, P.H. (2000) CD95's deadly mission in the immune system. Nature 407: 789-795.
23. Kuwana, T., Smith, J.J., Muzio, M., Dixit, V., Newmeyer, D.D., and Kornbluth, S. (1998) Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem 273: 16589-16594.
24. Li, H., Zhu, H., Xu, C., and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
25. Lieberman, J. (2003) The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal. Nat Rev Immunol 3: 361-370.
26. Lüder, C.G.K. (2006) Survival strategies of Toxoplasma gondii: interference with regulatory and effector functions of macrophages. In Protozoans in Macrophages. Denkers, E.Y., and Gazzinelli, R.T. (eds). Georgetown, TX: Landes Bioscience. [Online] http://eurekah.com.
27. Lüder, C.G.K., and Gross, U. (2005) Apoptosis and its modulation during infection with Toxoplasma gondii: Molecular mechanisms and role in pathogenesis. In Role of Apoptosis in Infection. Griffin, D.E. (ed.) Curr Top Microbiol Immunol 289. Heidelberg: Springer, pp. 219-237.
28. Luft, B.J., Hafner, R., Korzun, A.H., Leport, C., Antoniskis, D., Bosler, E.M., et al. (1993) Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 329: 995-1000.
29. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface receptors. Cell 94: 481-490.
30. Medema, J.P., Scaffidi, C., Kischkel, F.C., Shevchenko, A., Mann, M., Krammer, P.H., and Peter, M.E. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16: 2794-2804.
31. Miller, S.A., Binder, E.M., Blackman, M.J., Carruthers, V.B., and Kim, K. (2001) A conserved subtilisin-like protein TgSUB1 in microneme organelles of Toxoplasma gondii. J Biol Chem 276: 45341-45348.
32. Molestina, R.E., Payne, T.M., Coppens, I., and Sinai, A.P. (2003) Activation of NF-κB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IκB to the parasitophorous vacuole membrane. J Cell Sci 116: 4359-4371.
33. Nash, P.B., Purner, M.B., Leon, R.P., Clarke, P., Duke, R.C., and Curiel, T.J. (1998) Toxoplasma gondii -infected cells are resistant to multiple inducers of apoptosis. J Immunol 160: 1824-1830.
34. Nicholson, D.W. (2000) From bench to clinic with apoptosis-based therapeutic agents. Nature 407: 810-816.
35. Opferman, J.T., and Korsmeyer, S.J. (2003) Apoptosis in the development and maintenance of the immune system. Nat Immunol 4: 410-415.
36. Orlofsky, A., Weiss, L.M., Kawachi, N., and Prystowsky, M.B. (2002) Deficiency in the anti-apoptotic protein A1-a results in a diminished acute inflammatory response. J Immunol 168: 1840-1846.
37. Payne, T.M., Molestina, R.E., and Sinai, A.P. (2003) Inhibition of caspase activation and a requirement for NF-κB function in the Toxoplasma gondii -mediated blockade of host apoptosis. J Cell Sci 116: 4345-4358.
38. Que, X., Ngo, H., Lawton, J., Gray, M., Liu, Q., Engel, J., et al. (2002) The cathepsin B of Toxoplasma gondii, toxopain-1, is critical for parasite invasion and rhoptry protein processing. J Biol Chem 277: 25791-25797.
39. Riedl, S.J., and Shi, Y. (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897-907.
40. Salmena, L., Lemmers, B., Hakem, A., Matysiak-Zablocki, E., Murakami, K., Au, P.Y., et al. (2003) Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 17: 883-895.
41. Samraj, A.K., Keil, E., Ueffing, N., Schulze-Osthoff, K., and Schmitz, I. (2006) Loss of caspase-9 provides genetic evidence for the type I/II concept of CD95-mediated apoptosis. J Biol Chem 281: 29652-29659.
42. Scaffidi, C., Medema, J.P., Krammer, P.H., and Peter, M.E. (1997) FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase 8/b. J Biol Chem 272: 26953-26958.
43. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K.J., et al. (1998) Two CD95 (APO-1/Fas) signalling pathways. EMBO J 17: 1675-1687.
44. Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S.J., Krammer, P.H., and Peter, M.E. (1999a) Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274: 22532-22538.
45. Scaffidi, C., Schmitz, I., Krammer, P.H., and Peter, M.E. (1999b) The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274: 1541-1548.
46. Shi, Y. (2004) Caspase activation, inhibition, and reactivation: A mechanistic view. Protein Sci 13: 1979-1987.
47. Silva, E.M., Guillermo, L.V.C., Ribeiro-Gomes, F.L., de Meis, J., Pereira, R.M.S., Wu, Z., et al. (2005) Caspase-8 activity prevents type 2 cytokine responses and is required for protective T cell-mediated immunity against Trypanosoma cruzi infection. J Immunol 174: 6314-6321.
48. Su, H., Bidere, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., et al. (2005) Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 307: 1465-1468.
49. Sukthana, Y. (2006) Toxoplasmosis: Beyond animals to humans. Trends Parasitol 22: 137-142.
50. Wesselborg, S., Engels, I.H., Rossmann, E., Los, M., and Schulze-Osthoff, K. (1999) Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood 93: 3053-3063.
51. Williams, G.T. (1994) Programmed cell death: A fundamental protective response to pathogens. Trends Microbiol 2: 463-464.
52. Wong, S., and Remington, J.S. (1994) Toxoplasmosis in pregnancy. Clin Infect Dis 18: 853-862.
53. Yang, X., Chang, H.Y., and Baltimore, D. (1998) Autoproteolytic activation of pro-caspases by oligomerization. Mol Cell 1: 319-325.